LifeMD, Inc. $LFMD Holdings Increased by Caitong International Asset Management Co. Ltd

Caitong International Asset Management Co. Ltd grew its stake in shares of LifeMD, Inc. (NASDAQ:LFMD) by 1,004.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,171 shares of the company’s stock after buying an additional 4,703 shares during the quarter. Caitong International Asset Management Co. Ltd’s holdings in LifeMD were worth $70,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Magnus Financial Group LLC bought a new stake in shares of LifeMD during the 2nd quarter worth about $218,000. Wealth Enhancement Advisory Services LLC bought a new stake in shares of LifeMD during the 2nd quarter worth about $193,000. Baader Bank Aktiengesellschaft bought a new stake in shares of LifeMD during the 2nd quarter worth about $136,000. Mirador Capital Partners LP raised its position in shares of LifeMD by 34.4% during the 2nd quarter. Mirador Capital Partners LP now owns 154,965 shares of the company’s stock worth $2,111,000 after buying an additional 39,623 shares in the last quarter. Finally, Uniplan Investment Counsel Inc. raised its position in shares of LifeMD by 0.8% during the 1st quarter. Uniplan Investment Counsel Inc. now owns 388,288 shares of the company’s stock worth $2,112,000 after buying an additional 3,035 shares in the last quarter. 35.52% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider Nicholas P. Alvarez sold 75,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $5.92, for a total transaction of $444,000.00. Following the sale, the insider owned 605,000 shares in the company, valued at $3,581,600. The trade was a 11.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 18.40% of the stock is owned by corporate insiders.

LifeMD Stock Up 1.1%

LFMD stock opened at $6.30 on Friday. LifeMD, Inc. has a 52-week low of $3.99 and a 52-week high of $15.84. The company’s 50 day simple moving average is $6.32 and its 200-day simple moving average is $8.69. The company has a debt-to-equity ratio of 9.21, a current ratio of 0.77 and a quick ratio of 0.72. The firm has a market capitalization of $298.75 million, a P/E ratio of -30.00 and a beta of 1.67.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of LifeMD in a research report on Wednesday, October 8th. Lake Street Capital dropped their target price on shares of LifeMD from $18.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, August 6th. HC Wainwright dropped their target price on shares of LifeMD from $14.00 to $13.00 and set a “buy” rating on the stock in a report on Thursday, August 7th. KeyCorp dropped their target price on shares of LifeMD from $14.00 to $12.00 and set an “overweight” rating on the stock in a report on Wednesday, August 6th. Finally, Zacks Research raised LifeMD from a “strong sell” rating to a “hold” rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $13.17.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.